Correction: Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication

Sacramento, Carolina Q., de Melo, Gabrielle R., de Freitas, Caroline S.,Rocha, Natasha, Hoelz, Lucas Villas Bôas, Miranda, Milene, Fintelman-Rodrigues, Natalia,Marttorelli, Andressa, Ferreira, André C.,Barbosa-Lima, Giselle, Abrantes, Juliana L., Vieira, Yasmine Rangel, Bastos, Mônica M., Volotão, Eduardo de Mello, Nunes, Estevão Portela, Tschoeke, Diogo A.,Leomil, Luciana, Loiola, Erick Correia, Trindade, Pablo, Rehen, Stevens K., Bozza, Fernando A., Bozza, Patrícia T., Boechat, Nubia, Thompson, Fabiano L., de Filippis, Ana M. B.,Brüning, Karin, Souza, Thiago Moreno L.

Scientific Reports（2017）

引用 0|浏览0

暂无评分

摘要

Scientific Reports 7: Article number: 40920; published online 18 January 2017; updated on 24 April 2017 The Competing Financial Interests section in this Article is incorrect and should read: “Dr. Karin Brüning is a member of the BMK consortium, able to produce sofosbuvir”.

查看译文

关键词

Antivirals,Pharmacology,Viral infection,Science,Humanities and Social Sciences,multidisciplinary

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要